<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA051289-0048</title>
	</head>
	<body>
		<main>
			<p><P> May 12, 1989, Friday, Southland Edition  </P> <P> OREGON BIOTECH COMPANY RECEIVES OK TO SELL SHARES  </P> <P> Epitope Inc. announced that the Securities and Exchange Commission has approved  its sale of 1.25 million shares of common stock at $5 each.  </P> <P> Shares in the biotechnology company are being sold to a limited number of U.S.  and European institutional and other qualified investors, officials said. Sutro  &amp; Co. of San Francisco is the underwriter for the stock offering.  </P> <P> Net proceeds from the offering will be used in development of new diagnostic  tests for AIDS, therapeutic drugs for malaria, antiviral barriers and novel  plant varieties, as well as general corporate purposes, Epitope officials said.  </P></p>
		</main>
</body></html>
            